Alexander Horswill
Concepts (659)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 122 | 2026 | 459 | 26.680 |
Why?
| | Staphylococcal Infections | 97 | 2025 | 397 | 21.850 |
Why?
| | Bacterial Proteins | 94 | 2026 | 980 | 11.620 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 45 | 2026 | 253 | 11.420 |
Why?
| | Biofilms | 56 | 2025 | 288 | 10.640 |
Why?
| | Quorum Sensing | 38 | 2026 | 80 | 8.520 |
Why?
| | Skin | 24 | 2026 | 701 | 6.040 |
Why?
| | Gene Expression Regulation, Bacterial | 41 | 2026 | 340 | 5.340 |
Why?
| | Staphylococcus epidermidis | 24 | 2024 | 80 | 5.170 |
Why?
| | Staphylococcal Skin Infections | 12 | 2026 | 40 | 4.730 |
Why?
| | Virulence Factors | 27 | 2026 | 175 | 4.290 |
Why?
| | Virulence | 31 | 2026 | 288 | 3.450 |
Why?
| | Staphylococcus | 11 | 2022 | 74 | 3.300 |
Why?
| | Trans-Activators | 20 | 2026 | 372 | 3.070 |
Why?
| | Anti-Bacterial Agents | 35 | 2025 | 1942 | 2.960 |
Why?
| | Peptides, Cyclic | 19 | 2019 | 276 | 2.830 |
Why?
| | Bacterial Adhesion | 14 | 2025 | 109 | 2.810 |
Why?
| | Adhesins, Bacterial | 10 | 2026 | 46 | 2.470 |
Why?
| | Host-Pathogen Interactions | 15 | 2026 | 366 | 2.470 |
Why?
| | Peptides | 17 | 2024 | 992 | 2.050 |
Why?
| | Neutrophils | 23 | 2026 | 1133 | 1.950 |
Why?
| | Mice | 66 | 2026 | 18297 | 1.670 |
Why?
| | Protein Kinases | 9 | 2026 | 311 | 1.670 |
Why?
| | Phagocytosis | 12 | 2026 | 298 | 1.570 |
Why?
| | Animals | 93 | 2026 | 38107 | 1.570 |
Why?
| | Teichoic Acids | 5 | 2026 | 21 | 1.560 |
Why?
| | Micrococcal Nuclease | 7 | 2024 | 26 | 1.490 |
Why?
| | Dermatitis, Atopic | 4 | 2024 | 319 | 1.460 |
Why?
| | Hemolysin Proteins | 9 | 2018 | 37 | 1.430 |
Why?
| | Keratinocytes | 8 | 2025 | 190 | 1.370 |
Why?
| | Lipoproteins | 5 | 2024 | 165 | 1.330 |
Why?
| | Membrane Proteins | 8 | 2024 | 1130 | 1.300 |
Why?
| | Cell Wall | 4 | 2026 | 61 | 1.220 |
Why?
| | Peptide Hydrolases | 11 | 2024 | 105 | 1.220 |
Why?
| | Bacterial Toxins | 13 | 2023 | 110 | 1.210 |
Why?
| | Mutagenesis | 3 | 2025 | 196 | 1.160 |
Why?
| | Immune Evasion | 8 | 2026 | 64 | 1.120 |
Why?
| | Coinfection | 4 | 2023 | 143 | 1.110 |
Why?
| | Staphylococcus hominis | 2 | 2025 | 5 | 1.110 |
Why?
| | Streptococcus pyogenes | 3 | 2026 | 41 | 1.100 |
Why?
| | Microbial Sensitivity Tests | 15 | 2025 | 367 | 1.080 |
Why?
| | Humans | 114 | 2026 | 146342 | 1.020 |
Why?
| | Pruritus | 2 | 2024 | 61 | 1.000 |
Why?
| | Prosthesis-Related Infections | 3 | 2025 | 100 | 0.960 |
Why?
| | Fibrinogen | 6 | 2023 | 182 | 0.940 |
Why?
| | Microbial Interactions | 2 | 2019 | 20 | 0.930 |
Why?
| | Vagina | 3 | 2025 | 202 | 0.930 |
Why?
| | Bacteriocins | 1 | 2025 | 5 | 0.930 |
Why?
| | DNA, Bacterial | 7 | 2024 | 319 | 0.920 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 113 | 0.920 |
Why?
| | Culture Media | 4 | 2024 | 161 | 0.910 |
Why?
| | Urease | 1 | 2025 | 13 | 0.900 |
Why?
| | Polysaccharide-Lyases | 2 | 2016 | 11 | 0.900 |
Why?
| | Propionates | 8 | 2020 | 39 | 0.880 |
Why?
| | Repressor Proteins | 4 | 2015 | 430 | 0.850 |
Why?
| | Genome, Bacterial | 1 | 2025 | 122 | 0.820 |
Why?
| | Extracellular Space | 4 | 2014 | 118 | 0.790 |
Why?
| | Collagen | 1 | 2026 | 460 | 0.770 |
Why?
| | Wound Infection | 4 | 2026 | 60 | 0.760 |
Why?
| | Endodeoxyribonucleases | 1 | 2023 | 77 | 0.730 |
Why?
| | Mutation | 27 | 2026 | 4093 | 0.720 |
Why?
| | Microbiota | 7 | 2025 | 725 | 0.700 |
Why?
| | Homeostasis | 2 | 2025 | 646 | 0.700 |
Why?
| | Cysteine Endopeptidases | 3 | 2025 | 81 | 0.690 |
Why?
| | Bacteremia | 4 | 2020 | 218 | 0.680 |
Why?
| | Cathepsin G | 1 | 2021 | 4 | 0.680 |
Why?
| | Metalloproteases | 2 | 2020 | 42 | 0.680 |
Why?
| | Agglutination Tests | 1 | 2021 | 4 | 0.660 |
Why?
| | Cell Membrane | 7 | 2021 | 701 | 0.660 |
Why?
| | Symbiosis | 2 | 2020 | 71 | 0.650 |
Why?
| | Microbial Viability | 3 | 2018 | 83 | 0.640 |
Why?
| | Metalloendopeptidases | 5 | 2017 | 63 | 0.640 |
Why?
| | Mice, Inbred C57BL | 20 | 2026 | 6034 | 0.630 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 588 | 0.620 |
Why?
| | Streptococcal Infections | 5 | 2026 | 179 | 0.610 |
Why?
| | Mass Spectrometry | 8 | 2019 | 729 | 0.610 |
Why?
| | Disease Models, Animal | 21 | 2026 | 4580 | 0.600 |
Why?
| | Immunity, Innate | 9 | 2026 | 844 | 0.590 |
Why?
| | Rabbits | 10 | 2019 | 651 | 0.580 |
Why?
| | Plant Extracts | 4 | 2020 | 192 | 0.580 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 77 | 0.570 |
Why?
| | Membrane Transport Proteins | 1 | 2020 | 154 | 0.570 |
Why?
| | Protein Binding | 11 | 2026 | 2244 | 0.560 |
Why?
| | Salmonella enterica | 6 | 2003 | 52 | 0.550 |
Why?
| | Streptococcus agalactiae | 4 | 2026 | 118 | 0.550 |
Why?
| | Dehydration | 1 | 2018 | 59 | 0.530 |
Why?
| | Antibiosis | 1 | 2017 | 10 | 0.530 |
Why?
| | Yersinia pestis | 3 | 2013 | 45 | 0.530 |
Why?
| | Disease Transmission, Infectious | 1 | 2018 | 69 | 0.530 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2025 | 534 | 0.510 |
Why?
| | Carrier Proteins | 4 | 2022 | 728 | 0.510 |
Why?
| | Coenzyme A Ligases | 4 | 2003 | 15 | 0.500 |
Why?
| | Salmonella typhimurium | 7 | 2004 | 194 | 0.500 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.490 |
Why?
| | Catheter-Related Infections | 8 | 2022 | 101 | 0.480 |
Why?
| | Operating Rooms | 1 | 2018 | 145 | 0.480 |
Why?
| | Pseudomonas aeruginosa | 7 | 2023 | 392 | 0.470 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.460 |
Why?
| | Genes, Bacterial | 8 | 2014 | 151 | 0.460 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.450 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.450 |
Why?
| | Bacteriological Techniques | 2 | 2014 | 66 | 0.450 |
Why?
| | Mice, Inbred BALB C | 7 | 2022 | 1244 | 0.440 |
Why?
| | Models, Molecular | 11 | 2021 | 1574 | 0.430 |
Why?
| | Lactones | 2 | 2013 | 60 | 0.430 |
Why?
| | Gram-Positive Bacteria | 2 | 2017 | 48 | 0.430 |
Why?
| | Transduction, Genetic | 2 | 2014 | 129 | 0.430 |
Why?
| | Environment | 1 | 2016 | 299 | 0.410 |
Why?
| | Endonucleases | 1 | 2014 | 35 | 0.410 |
Why?
| | Macrophages | 6 | 2026 | 1532 | 0.410 |
Why?
| | Hyaluronic Acid | 1 | 2016 | 227 | 0.400 |
Why?
| | Peptide Library | 6 | 2007 | 91 | 0.400 |
Why?
| | Extracellular Matrix | 3 | 2020 | 565 | 0.400 |
Why?
| | beta-Lactams | 2 | 2016 | 34 | 0.390 |
Why?
| | Citrates | 4 | 2004 | 41 | 0.380 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 16 | 0.380 |
Why?
| | Plasmids | 7 | 2013 | 373 | 0.380 |
Why?
| | Bone Remodeling | 1 | 2013 | 71 | 0.380 |
Why?
| | Bacteriophages | 2 | 2014 | 110 | 0.370 |
Why?
| | Lectins | 2 | 2024 | 44 | 0.370 |
Why?
| | Sigma Factor | 2 | 2011 | 47 | 0.370 |
Why?
| | Bacillus thuringiensis | 1 | 2012 | 6 | 0.370 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.370 |
Why?
| | Berberine | 1 | 2012 | 5 | 0.370 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 952 | 0.360 |
Why?
| | Superantigens | 4 | 2013 | 70 | 0.360 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1468 | 0.360 |
Why?
| | Epithelial Cells | 4 | 2024 | 1119 | 0.360 |
Why?
| | Gene Library | 2 | 2010 | 121 | 0.360 |
Why?
| | Synovial Fluid | 4 | 2022 | 69 | 0.360 |
Why?
| | Pneumonia, Bacterial | 2 | 2023 | 114 | 0.350 |
Why?
| | Fibronectins | 3 | 2022 | 136 | 0.350 |
Why?
| | Coagulase | 3 | 2021 | 6 | 0.340 |
Why?
| | Locomotion | 1 | 2012 | 102 | 0.340 |
Why?
| | Operon | 7 | 2026 | 67 | 0.340 |
Why?
| | Cytotoxins | 3 | 2024 | 15 | 0.340 |
Why?
| | Proteins | 3 | 2006 | 1022 | 0.330 |
Why?
| | Female | 31 | 2026 | 79499 | 0.330 |
Why?
| | Genes, Reporter | 3 | 2019 | 275 | 0.330 |
Why?
| | Osteomyelitis | 1 | 2013 | 148 | 0.330 |
Why?
| | Extracellular Traps | 2 | 2021 | 54 | 0.330 |
Why?
| | Signal Transduction | 10 | 2024 | 5246 | 0.330 |
Why?
| | Community-Acquired Infections | 2 | 2010 | 179 | 0.330 |
Why?
| | Serine Endopeptidases | 3 | 2011 | 129 | 0.320 |
Why?
| | Amoxicillin | 2 | 2024 | 35 | 0.310 |
Why?
| | Plasma | 1 | 2012 | 222 | 0.310 |
Why?
| | Internal Fixators | 1 | 2010 | 32 | 0.300 |
Why?
| | Luminescent Proteins | 3 | 2011 | 188 | 0.300 |
Why?
| | Peptide Biosynthesis | 1 | 2009 | 13 | 0.300 |
Why?
| | Amino Acid Sequence | 11 | 2016 | 2092 | 0.300 |
Why?
| | Models, Biological | 8 | 2021 | 1761 | 0.290 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2838 | 0.290 |
Why?
| | Anacardiaceae | 2 | 2020 | 4 | 0.290 |
Why?
| | Anti-Infective Agents | 4 | 2023 | 234 | 0.280 |
Why?
| | Polysaccharides | 3 | 2021 | 88 | 0.280 |
Why?
| | Drug Discovery | 3 | 2019 | 154 | 0.270 |
Why?
| | Cells, Cultured | 9 | 2021 | 4118 | 0.270 |
Why?
| | Recombinant Proteins | 7 | 2015 | 1361 | 0.270 |
Why?
| | Inteins | 1 | 2007 | 1 | 0.260 |
Why?
| | DnaB Helicases | 1 | 2007 | 2 | 0.260 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.260 |
Why?
| | Cysteine Proteases | 2 | 2020 | 8 | 0.260 |
Why?
| | Sepsis | 3 | 2023 | 669 | 0.250 |
Why?
| | Extracellular Matrix Proteins | 2 | 2024 | 156 | 0.250 |
Why?
| | Hypochlorous Acid | 2 | 2025 | 8 | 0.250 |
Why?
| | Cyclohexanones | 2 | 2017 | 9 | 0.250 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1242 | 0.250 |
Why?
| | Interleukin-1beta | 3 | 2025 | 397 | 0.250 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 861 | 0.240 |
Why?
| | Acyl Coenzyme A | 4 | 2003 | 32 | 0.240 |
Why?
| | Biological Assay | 3 | 2015 | 133 | 0.240 |
Why?
| | Serine Proteases | 1 | 2026 | 26 | 0.240 |
Why?
| | Base Sequence | 4 | 2023 | 2123 | 0.230 |
Why?
| | Protein Engineering | 2 | 2004 | 122 | 0.230 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2014 | 382 | 0.230 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2025 | 198 | 0.220 |
Why?
| | Malassezia | 1 | 2025 | 5 | 0.220 |
Why?
| | Mycobiome | 1 | 2025 | 8 | 0.220 |
Why?
| | Gain of Function Mutation | 1 | 2025 | 35 | 0.220 |
Why?
| | Ammonia | 1 | 2025 | 61 | 0.220 |
Why?
| | Glycolipids | 1 | 2025 | 53 | 0.220 |
Why?
| | Phenols | 2 | 2023 | 106 | 0.220 |
Why?
| | Urea | 1 | 2025 | 84 | 0.220 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 2023 | 81 | 0.220 |
Why?
| | Porosity | 1 | 2025 | 95 | 0.210 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1041 | 0.210 |
Why?
| | Aconitate Hydratase | 2 | 2002 | 14 | 0.210 |
Why?
| | Molecular Biology | 1 | 2005 | 59 | 0.210 |
Why?
| | Adenosine Monophosphate | 2 | 2003 | 87 | 0.210 |
Why?
| | Escherichia coli | 3 | 2009 | 832 | 0.210 |
Why?
| | Diabetes Complications | 1 | 2026 | 219 | 0.210 |
Why?
| | Coculture Techniques | 2 | 2016 | 245 | 0.210 |
Why?
| | Androgens | 1 | 2026 | 179 | 0.210 |
Why?
| | Endocarditis | 2 | 2016 | 40 | 0.210 |
Why?
| | Isocitrates | 2 | 2001 | 2 | 0.210 |
Why?
| | Structure-Activity Relationship | 3 | 2023 | 563 | 0.210 |
Why?
| | Oxo-Acid-Lyases | 2 | 2001 | 3 | 0.210 |
Why?
| | Inflammation | 8 | 2023 | 2919 | 0.210 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2024 | 1 | 0.210 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 41 | 0.210 |
Why?
| | Corynebacterium | 1 | 2024 | 50 | 0.200 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 43 | 0.200 |
Why?
| | Biology | 1 | 2005 | 90 | 0.200 |
Why?
| | Trypsin | 1 | 2024 | 73 | 0.200 |
Why?
| | Inflammasomes | 1 | 2025 | 145 | 0.200 |
Why?
| | Receptor, PAR-1 | 1 | 2023 | 17 | 0.200 |
Why?
| | Mice, Knockout | 5 | 2026 | 3125 | 0.200 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1512 | 0.200 |
Why?
| | Succinates | 1 | 2023 | 25 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 104 | 0.200 |
Why?
| | Dermatitis | 1 | 2023 | 20 | 0.200 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 185 | 0.200 |
Why?
| | alpha-Defensins | 2 | 2021 | 11 | 0.200 |
Why?
| | Enzymes | 1 | 2004 | 60 | 0.200 |
Why?
| | Microscopy, Confocal | 3 | 2014 | 322 | 0.200 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 263 | 0.190 |
Why?
| | Swine | 4 | 2017 | 821 | 0.190 |
Why?
| | Microscopy, Fluorescence | 3 | 2016 | 404 | 0.190 |
Why?
| | Fatty Acids | 2 | 2025 | 460 | 0.190 |
Why?
| | RNA, Bacterial | 4 | 2013 | 183 | 0.190 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.190 |
Why?
| | Respiratory System | 2 | 2016 | 150 | 0.190 |
Why?
| | Enzyme Inhibitors | 5 | 2008 | 823 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2024 | 187 | 0.180 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 180 | 0.180 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2023 | 49 | 0.180 |
Why?
| | Wound Healing | 1 | 2025 | 354 | 0.180 |
Why?
| | Exotoxins | 2 | 2013 | 16 | 0.180 |
Why?
| | Substrate Specificity | 5 | 2026 | 389 | 0.180 |
Why?
| | Lipase | 2 | 2021 | 76 | 0.180 |
Why?
| | Thiazoles | 1 | 2023 | 139 | 0.180 |
Why?
| | Epidermis | 2 | 2020 | 72 | 0.180 |
Why?
| | Reactive Oxygen Species | 2 | 2024 | 610 | 0.180 |
Why?
| | Cephalexin | 1 | 2022 | 14 | 0.180 |
Why?
| | DNA Transposable Elements | 4 | 2010 | 125 | 0.180 |
Why?
| | Testosterone | 1 | 2026 | 419 | 0.170 |
Why?
| | Genotype | 4 | 2019 | 1879 | 0.170 |
Why?
| | Polysaccharides, Bacterial | 3 | 2017 | 70 | 0.170 |
Why?
| | Bacterial Load | 4 | 2015 | 68 | 0.170 |
Why?
| | Lipid Metabolism | 1 | 2025 | 533 | 0.170 |
Why?
| | Basophils | 1 | 2021 | 52 | 0.170 |
Why?
| | Cell Communication | 2 | 2018 | 327 | 0.170 |
Why?
| | Male | 22 | 2026 | 73396 | 0.170 |
Why?
| | Cell Death | 2 | 2021 | 379 | 0.170 |
Why?
| | Hair Follicle | 1 | 2021 | 35 | 0.160 |
Why?
| | Propionibacteriaceae | 1 | 2020 | 2 | 0.160 |
Why?
| | Pyruvic Acid | 1 | 2001 | 51 | 0.160 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2001 | 67 | 0.160 |
Why?
| | Interleukin-17 | 2 | 2019 | 121 | 0.160 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 77 | 0.160 |
Why?
| | Interleukin-4 | 1 | 2021 | 207 | 0.160 |
Why?
| | Orthopedic Equipment | 1 | 2020 | 5 | 0.160 |
Why?
| | Chemotaxis | 1 | 2021 | 121 | 0.160 |
Why?
| | Molecular Structure | 4 | 2020 | 484 | 0.160 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 1031 | 0.160 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2018 | 22 | 0.160 |
Why?
| | Phage Therapy | 1 | 2020 | 17 | 0.160 |
Why?
| | Photochemotherapy | 1 | 2020 | 39 | 0.160 |
Why?
| | Dysbiosis | 1 | 2022 | 184 | 0.160 |
Why?
| | Bacteria | 3 | 2023 | 766 | 0.160 |
Why?
| | Shear Strength | 1 | 2020 | 73 | 0.160 |
Why?
| | Fatty Acids, Volatile | 1 | 2020 | 61 | 0.160 |
Why?
| | Photosensitizing Agents | 1 | 2020 | 42 | 0.160 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 834 | 0.160 |
Why?
| | Netherton Syndrome | 1 | 2020 | 2 | 0.160 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 67 | 0.160 |
Why?
| | Triterpenes | 1 | 2020 | 27 | 0.150 |
Why?
| | Phylogeny | 1 | 2024 | 924 | 0.150 |
Why?
| | Blotting, Western | 4 | 2016 | 1177 | 0.150 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 147 | 0.150 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 125 | 0.150 |
Why?
| | Gene Deletion | 4 | 2014 | 385 | 0.150 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.150 |
Why?
| | Coleoptera | 1 | 2019 | 28 | 0.150 |
Why?
| | Genomics | 1 | 2005 | 853 | 0.150 |
Why?
| | Luciferases | 1 | 2019 | 153 | 0.150 |
Why?
| | Pyrazines | 1 | 2020 | 94 | 0.150 |
Why?
| | Lysine | 1 | 2002 | 303 | 0.150 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 51 | 0.150 |
Why?
| | Fruit | 1 | 2020 | 144 | 0.150 |
Why?
| | Leishmania major | 1 | 2019 | 8 | 0.150 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 14 | 0.150 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1792 | 0.140 |
Why?
| | Cathelicidins | 4 | 2023 | 40 | 0.140 |
Why?
| | Static Electricity | 1 | 2019 | 113 | 0.140 |
Why?
| | Models, Genetic | 2 | 2016 | 540 | 0.140 |
Why?
| | Skin Diseases | 2 | 2019 | 144 | 0.140 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 16 | 0.140 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 195 | 0.140 |
Why?
| | Pneumonia, Staphylococcal | 2 | 2018 | 26 | 0.140 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 193 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 176 | 0.130 |
Why?
| | Environmental Microbiology | 1 | 2018 | 46 | 0.130 |
Why?
| | Lung | 5 | 2022 | 4122 | 0.130 |
Why?
| | Bordetella bronchiseptica | 1 | 2017 | 2 | 0.130 |
Why?
| | Bordetella Infections | 1 | 2017 | 4 | 0.130 |
Why?
| | NADPH Oxidases | 2 | 2021 | 122 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 229 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 582 | 0.130 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1432 | 0.130 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 183 | 0.130 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 241 | 0.130 |
Why?
| | Conserved Sequence | 2 | 2011 | 242 | 0.120 |
Why?
| | Cell Line | 4 | 2015 | 2814 | 0.120 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 72 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 640 | 0.120 |
Why?
| | Endocarditis, Bacterial | 2 | 2013 | 46 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 487 | 0.120 |
Why?
| | Ligases | 1 | 2016 | 38 | 0.120 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 27 | 0.120 |
Why?
| | Vascular Access Devices | 1 | 2016 | 30 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 90 | 0.120 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2015 | 8 | 0.120 |
Why?
| | Leukocidins | 1 | 2015 | 2 | 0.110 |
Why?
| | Trachea | 1 | 2017 | 253 | 0.110 |
Why?
| | Periplasmic Binding Proteins | 1 | 2015 | 12 | 0.110 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 411 | 0.110 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.110 |
Why?
| | Multigene Family | 2 | 2013 | 210 | 0.110 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 335 | 0.110 |
Why?
| | Enterotoxins | 2 | 2013 | 89 | 0.110 |
Why?
| | Carbon | 2 | 2013 | 176 | 0.110 |
Why?
| | beta-Defensins | 1 | 2014 | 22 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 769 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 4 | 2021 | 125 | 0.110 |
Why?
| | Interleukin-8 | 3 | 2024 | 268 | 0.110 |
Why?
| | Kinetics | 4 | 2015 | 1553 | 0.110 |
Why?
| | Anthraquinones | 1 | 2014 | 10 | 0.110 |
Why?
| | Penicillium | 1 | 2014 | 8 | 0.100 |
Why?
| | Histocytochemistry | 1 | 2014 | 77 | 0.100 |
Why?
| | Quinazolinones | 1 | 2014 | 18 | 0.100 |
Why?
| | Structural Homology, Protein | 1 | 2014 | 21 | 0.100 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2014 | 5 | 0.100 |
Why?
| | Agglutination | 1 | 2013 | 5 | 0.100 |
Why?
| | Plant Leaves | 1 | 2015 | 134 | 0.100 |
Why?
| | Organisms, Genetically Modified | 1 | 2013 | 14 | 0.100 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.100 |
Why?
| | Virus Cultivation | 1 | 2014 | 31 | 0.100 |
Why?
| | DNA | 3 | 2022 | 1421 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2010 | 371 | 0.100 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 175 | 0.100 |
Why?
| | Nociceptors | 1 | 2013 | 40 | 0.100 |
Why?
| | Acyl-Butyrolactones | 1 | 2013 | 10 | 0.100 |
Why?
| | Cysteine | 2 | 2018 | 210 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2018 | 883 | 0.100 |
Why?
| | Receptors, LDL | 1 | 2013 | 53 | 0.090 |
Why?
| | Apolipoproteins B | 1 | 2013 | 48 | 0.090 |
Why?
| | Blotting, Northern | 1 | 2013 | 197 | 0.090 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 43 | 0.090 |
Why?
| | Surface Properties | 2 | 2014 | 384 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2020 | 2502 | 0.090 |
Why?
| | Transcription Factors | 5 | 2022 | 1730 | 0.090 |
Why?
| | Endopeptidase K | 2 | 2013 | 17 | 0.090 |
Why?
| | Triazoles | 1 | 2014 | 190 | 0.090 |
Why?
| | Plants, Medicinal | 1 | 2012 | 23 | 0.090 |
Why?
| | Protein Transport | 1 | 2014 | 443 | 0.090 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 80 | 0.090 |
Why?
| | Receptors, Interleukin-8B | 1 | 2012 | 29 | 0.090 |
Why?
| | Protein Conformation | 4 | 2026 | 916 | 0.090 |
Why?
| | Culture Media, Conditioned | 3 | 2020 | 112 | 0.090 |
Why?
| | Mycoplasma fermentans | 1 | 2012 | 1 | 0.090 |
Why?
| | Phenol | 1 | 2012 | 15 | 0.090 |
Why?
| | Mutagenesis, Insertional | 3 | 2009 | 68 | 0.090 |
Why?
| | Enzyme Therapy | 1 | 2011 | 4 | 0.090 |
Why?
| | Vancomycin | 1 | 2013 | 96 | 0.090 |
Why?
| | Erythrocytes | 2 | 2015 | 750 | 0.090 |
Why?
| | Alleles | 3 | 2020 | 907 | 0.090 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 16 | 0.090 |
Why?
| | Tetracyclines | 1 | 2011 | 16 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1309 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 410 | 0.090 |
Why?
| | Microarray Analysis | 3 | 2019 | 117 | 0.090 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2011 | 48 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 196 | 0.080 |
Why?
| | Incidence | 1 | 2018 | 2936 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 1164 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2011 | 360 | 0.080 |
Why?
| | Protease Inhibitors | 2 | 2010 | 103 | 0.080 |
Why?
| | RNA Polymerase III | 1 | 2010 | 34 | 0.080 |
Why?
| | Autolysis | 1 | 2010 | 3 | 0.080 |
Why?
| | Citrate (si)-Synthase | 2 | 2001 | 57 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 495 | 0.080 |
Why?
| | Pheromones | 1 | 2010 | 22 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 630 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 195 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 67 | 0.080 |
Why?
| | Chronic Disease | 1 | 2016 | 1827 | 0.080 |
Why?
| | Cytokines | 4 | 2023 | 2081 | 0.070 |
Why?
| | Adenosine Triphosphate | 2 | 2002 | 494 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 778 | 0.070 |
Why?
| | Titanium | 1 | 2010 | 74 | 0.070 |
Why?
| | Arthroplasty, Replacement | 1 | 2010 | 47 | 0.070 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 5 | 0.070 |
Why?
| | Biological Products | 1 | 2013 | 258 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 585 | 0.070 |
Why?
| | Shock, Septic | 1 | 2011 | 230 | 0.070 |
Why?
| | Ligands | 1 | 2011 | 678 | 0.070 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2008 | 3 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2014 | 334 | 0.070 |
Why?
| | Time Factors | 5 | 2020 | 7109 | 0.070 |
Why?
| | Polymers | 2 | 2022 | 488 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 830 | 0.070 |
Why?
| | Pain | 1 | 2013 | 790 | 0.070 |
Why?
| | Gene Knockout Techniques | 3 | 2013 | 122 | 0.070 |
Why?
| | Endopeptidase Clp | 1 | 2007 | 4 | 0.060 |
Why?
| | Prosthesis Design | 1 | 2010 | 358 | 0.060 |
Why?
| | Genetic Complementation Test | 3 | 2014 | 72 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 441 | 0.060 |
Why?
| | Drug Synergism | 2 | 2020 | 354 | 0.060 |
Why?
| | beta-Lactamases | 1 | 2007 | 54 | 0.060 |
Why?
| | Stimulation, Chemical | 1 | 2006 | 52 | 0.060 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 23 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2006 | 47 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2026 | 102 | 0.060 |
Why?
| | Respiratory Tract Infections | 1 | 2010 | 403 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 487 | 0.060 |
Why?
| | Burns | 1 | 2010 | 365 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2010 | 432 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8391 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2026 | 235 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 866 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 90 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 327 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2005 | 17 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 771 | 0.060 |
Why?
| | HIV Protease | 1 | 2004 | 4 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2009 | 1163 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2005 | 64 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2004 | 10 | 0.050 |
Why?
| | Caspase 1 | 1 | 2025 | 145 | 0.050 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 59 | 0.050 |
Why?
| | Ribonucleotide Reductases | 1 | 2004 | 29 | 0.050 |
Why?
| | Tricarboxylic Acids | 1 | 2004 | 11 | 0.050 |
Why?
| | Molecular Dynamics Simulation | 1 | 2026 | 267 | 0.050 |
Why?
| | Phenotype | 3 | 2021 | 3206 | 0.050 |
Why?
| | DNA Restriction Enzymes | 1 | 2004 | 46 | 0.050 |
Why?
| | Bacillus subtilis | 2 | 2020 | 67 | 0.050 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 22 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2005 | 239 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2004 | 105 | 0.050 |
Why?
| | Catalysis | 2 | 2002 | 304 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2439 | 0.050 |
Why?
| | Oligosaccharides | 1 | 2023 | 62 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 107 | 0.050 |
Why?
| | Acetate-CoA Ligase | 1 | 2003 | 2 | 0.050 |
Why?
| | Coenzyme A | 1 | 2003 | 8 | 0.050 |
Why?
| | Computational Biology | 2 | 2005 | 678 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 282 | 0.050 |
Why?
| | Recombinases | 1 | 2022 | 10 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 5 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 5 | 0.050 |
Why?
| | Oxidative Stress | 3 | 2014 | 1369 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 10 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 8 | 0.050 |
Why?
| | Protein Stability | 2 | 2013 | 180 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 846 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 22 | 0.050 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2002 | 31 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 408 | 0.040 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2002 | 11 | 0.040 |
Why?
| | Aged | 2 | 2023 | 26432 | 0.040 |
Why?
| | Middle Aged | 3 | 2020 | 36619 | 0.040 |
Why?
| | Leukocytes | 2 | 2015 | 301 | 0.040 |
Why?
| | Ecosystem | 1 | 2006 | 483 | 0.040 |
Why?
| | U937 Cells | 2 | 2012 | 28 | 0.040 |
Why?
| | Models, Chemical | 2 | 2002 | 252 | 0.040 |
Why?
| | Hydrodynamics | 1 | 2022 | 50 | 0.040 |
Why?
| | Viscosity | 1 | 2022 | 91 | 0.040 |
Why?
| | Tyrosine | 1 | 2022 | 217 | 0.040 |
Why?
| | Propylene Glycol | 2 | 1998 | 9 | 0.040 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 13 | 0.040 |
Why?
| | Proteolysis | 2 | 2012 | 174 | 0.040 |
Why?
| | Lipoylation | 1 | 2021 | 17 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2002 | 218 | 0.040 |
Why?
| | Photorhabdus | 1 | 2001 | 1 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 54 | 0.040 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2001 | 3 | 0.040 |
Why?
| | Aconitic Acid | 1 | 2001 | 1 | 0.040 |
Why?
| | Nematoda | 1 | 2001 | 12 | 0.040 |
Why?
| | Oxaloacetic Acid | 1 | 2001 | 4 | 0.040 |
Why?
| | Glutamate Synthase | 1 | 2001 | 2 | 0.040 |
Why?
| | Codon, Initiator | 1 | 2001 | 11 | 0.040 |
Why?
| | Cell-Free System | 1 | 2001 | 54 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2001 | 58 | 0.040 |
Why?
| | Brain | 1 | 2013 | 2991 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 455 | 0.040 |
Why?
| | Pentanoic Acids | 1 | 2020 | 2 | 0.040 |
Why?
| | Isobutyrates | 1 | 2020 | 2 | 0.040 |
Why?
| | Adult | 3 | 2020 | 41087 | 0.040 |
Why?
| | Hemiterpenes | 1 | 2020 | 8 | 0.040 |
Why?
| | Sequence Deletion | 2 | 2012 | 190 | 0.040 |
Why?
| | Hemolysis | 2 | 2013 | 242 | 0.040 |
Why?
| | Desmoglein 1 | 1 | 2020 | 2 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 326 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2002 | 627 | 0.040 |
Why?
| | Crystallography, X-Ray | 3 | 2011 | 477 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1724 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2020 | 90 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 34 | 0.040 |
Why?
| | Monocytes | 2 | 2013 | 538 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 508 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 240 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2022 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2019 | 75 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 736 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2023 | 370 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1133 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 1999 | 143 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 636 | 0.040 |
Why?
| | Interferon Type I | 1 | 2019 | 147 | 0.040 |
Why?
| | Nucleotidyltransferases | 1 | 1998 | 30 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 1998 | 65 | 0.030 |
Why?
| | Triglycerides | 1 | 2021 | 527 | 0.030 |
Why?
| | Animals, Newborn | 2 | 2012 | 888 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2020 | 497 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2019 | 447 | 0.030 |
Why?
| | Th17 Cells | 1 | 2019 | 103 | 0.030 |
Why?
| | Survival Analysis | 2 | 2012 | 1378 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2018 | 162 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2017 | 12 | 0.030 |
Why?
| | Iron | 1 | 2019 | 359 | 0.030 |
Why?
| | Genes, Regulator | 1 | 1997 | 34 | 0.030 |
Why?
| | Nose | 1 | 2017 | 67 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 576 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2011 | 901 | 0.030 |
Why?
| | Blood Coagulation | 1 | 2018 | 267 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 340 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 42 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 781 | 0.030 |
Why?
| | Ethanolamines | 1 | 1995 | 14 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 243 | 0.030 |
Why?
| | Propylene Glycols | 1 | 1995 | 27 | 0.030 |
Why?
| | DNA Polymerase I | 1 | 1995 | 31 | 0.030 |
Why?
| | Bronchi | 1 | 2017 | 263 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 951 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 30 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 16 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 58 | 0.030 |
Why?
| | Child | 3 | 2022 | 22693 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 103 | 0.030 |
Why?
| | Mice, Hairless | 1 | 2014 | 45 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 2014 | 48 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 137 | 0.030 |
Why?
| | Neisseria gonorrhoeae | 1 | 2014 | 29 | 0.030 |
Why?
| | Pyomyositis | 1 | 2014 | 15 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 141 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 121 | 0.030 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2013 | 3 | 0.020 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 56 | 0.020 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 38 | 0.020 |
Why?
| | Lymphatic Diseases | 1 | 2013 | 21 | 0.020 |
Why?
| | Myeloid Cells | 1 | 2015 | 149 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2240 | 0.020 |
Why?
| | Fluorescence | 1 | 2014 | 160 | 0.020 |
Why?
| | Glyoxylates | 1 | 2013 | 8 | 0.020 |
Why?
| | Oxidants | 1 | 2013 | 100 | 0.020 |
Why?
| | Host Specificity | 1 | 2013 | 33 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2015 | 201 | 0.020 |
Why?
| | Fermentation | 1 | 2013 | 31 | 0.020 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 16 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2013 | 32 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2015 | 339 | 0.020 |
Why?
| | Carbohydrates | 1 | 2013 | 66 | 0.020 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 6 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2014 | 155 | 0.020 |
Why?
| | Regulon | 1 | 2013 | 34 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 78 | 0.020 |
Why?
| | Daptomycin | 1 | 2012 | 18 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 87 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 759 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 119 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2013 | 127 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 416 | 0.020 |
Why?
| | Immunoassay | 1 | 2013 | 108 | 0.020 |
Why?
| | Ion Transport | 1 | 2012 | 61 | 0.020 |
Why?
| | Bicarbonates | 1 | 2012 | 44 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 82 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 64 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 179 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 115 | 0.020 |
Why?
| | Crystallization | 2 | 2003 | 131 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2921 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1996 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2012 | 84 | 0.020 |
Why?
| | Body Fluids | 1 | 2012 | 70 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 88 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 337 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 340 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 511 | 0.020 |
Why?
| | Glycerophosphates | 1 | 2011 | 4 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2011 | 24 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 246 | 0.020 |
Why?
| | Complement C3-C5 Convertases | 1 | 2011 | 22 | 0.020 |
Why?
| | Immunoglobulin Fragments | 1 | 2011 | 11 | 0.020 |
Why?
| | Complement C3b | 1 | 2011 | 30 | 0.020 |
Why?
| | Rodent Diseases | 1 | 2011 | 28 | 0.020 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 143 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 447 | 0.020 |
Why?
| | Bacitracin | 1 | 2010 | 5 | 0.020 |
Why?
| | Complement C3a | 1 | 2011 | 40 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2011 | 37 | 0.020 |
Why?
| | Neomycin | 1 | 2010 | 7 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 24 | 0.020 |
Why?
| | Polymyxin B | 1 | 2010 | 22 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 294 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 100 | 0.020 |
Why?
| | Bacteriolysis | 1 | 2010 | 10 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 974 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 105 | 0.020 |
Why?
| | Gentamicins | 1 | 2010 | 50 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2011 | 224 | 0.020 |
Why?
| | Hot Temperature | 1 | 2013 | 396 | 0.020 |
Why?
| | Meconium | 1 | 2010 | 9 | 0.020 |
Why?
| | Ileus | 1 | 2010 | 14 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2010 | 24 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 841 | 0.020 |
Why?
| | Action Potentials | 1 | 2013 | 500 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 450 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 384 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2012 | 247 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 750 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 64 | 0.020 |
Why?
| | Mucus | 1 | 2010 | 75 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2010 | 73 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 42 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 356 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 870 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2010 | 174 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 858 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2537 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 373 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1298 | 0.020 |
Why?
| | Complement Activation | 1 | 2011 | 412 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 1036 | 0.020 |
Why?
| | Caulobacter crescentus | 1 | 2007 | 2 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 997 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 829 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 7230 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2012 | 887 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 1068 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2134 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3416 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2791 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2599 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2012 | 2012 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 185 | 0.010 |
Why?
| | Acetylation | 1 | 2003 | 262 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3926 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 663 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 3034 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 22557 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 526 | 0.010 |
Why?
| | Reproduction | 1 | 2001 | 209 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1998 | 7 | 0.010 |
Why?
| | Ethanolamine | 1 | 1995 | 6 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 32 | 0.010 |
Why?
| | Rats | 1 | 1995 | 5586 | 0.000 |
Why?
|
|
Horswill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|